Precision medicine for the treatment of sepsis: recent advances and future prospects

2019 ◽  
Vol 4 (4) ◽  
pp. 205-213 ◽  
Author(s):  
Pedro Palma ◽  
Jordi Rello
Keyword(s):  
Precision Medicine ◽  
Future Prospects ◽  
Recent Advances

Recent advances in graphene electronic skin and its future prospects

ChemNanoMat ◽  
2021 ◽  
Author(s):  
Yan Zhou ◽  
Dongfang Dai ◽  
Yu Gao ◽  
Zhengdong Zhang ◽  
Nan Sun ◽  
...  
Keyword(s):  
Future Prospects ◽  
Electronic Skin ◽  
Recent Advances

Recent Advances and Future Prospects in Peptaibiotics, Hydrophobin, and Mycotoxin Research, and Their Importance for Chemotaxonomy ofTrichoderma andHypocrea

2008 ◽  
Vol 5 (5) ◽  
pp. 671-680 ◽  
Author(s):  
Thomas Degenkolb ◽  
Hans von Döhren ◽  
Kristian Fog Nielsen ◽  
Gary J. Samuels ◽  
Hans Brückner
Keyword(s):  
Mycotoxin Research ◽  
Future Prospects ◽  
Recent Advances

Proteogenomics for understanding oncology: recent advances and future prospects

2016 ◽  
Vol 13 (3) ◽  
pp. 297-308 ◽  
Author(s):  
Yashwanth Subbannayya ◽  
Sneha M. Pinto ◽  
Harsha Gowda ◽  
T. S. Keshava Prasad
Keyword(s):  
Future Prospects ◽  
Recent Advances

scholarly journals The integration of emerging omics approaches to advance precision medicine: How can regulatory science help?

2018 ◽  
Vol 2 (5) ◽  
pp. 295-300
Author(s):  
Joan E. Adamo ◽  
Robert V. Bienvenu ◽  
F. Owen Fields ◽  
Soma Ghosh ◽  
Christina M. Jones ◽  
...  
Keyword(s):  
Next Generation Sequencing ◽  
Precision Medicine ◽  
Working Group ◽  
Regulatory Science ◽  
Translational Science ◽  
Next Generation ◽  
Clinical Validity ◽  
Knowledge Gaps ◽  
Recent Advances ◽  
Generation Sequencing

Building on the recent advances in next-generation sequencing, the integration of genomics, proteomics, metabolomics, and other approaches hold tremendous promise for precision medicine. The approval and adoption of these rapidly advancing technologies and methods presents several regulatory science considerations that need to be addressed. To better understand and address these regulatory science issues, a Clinical and Translational Science Award Working Group convened the Regulatory Science to Advance Precision Medicine Forum. The Forum identified an initial set of regulatory science gaps. The final set of key findings and recommendations provided here address issues related to the lack of standardization of complex tests, preclinical issues, establishing clinical validity and utility, pharmacogenomics considerations, and knowledge gaps.

Sign in / Sign up

Export Citation Format

Share Document